BeStock  
Stocks › Biotechnology › ODTX

Odyssey Therapeutics ODTX

US equityMarket cap rank #3291Biotechnology
$16.96 −$1.38 (-7.52%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.96 0.00%
Open$17.65
Prev close$18.34
Day range$16.46 – $18.08
Volume677.8K
Market cap$815.23M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership92.1%+4.43 pts vs. prior quarter
Institutions holding80+16 vs. prior quarter
Insider trades (recent)19 buys / 5 sellsNet buying
Short interest6.97% of floatDays to cover 15.4 · as of 30 Oct 2026
Short-sale volume share37.9%5-day average of daily volume

Short-sale volume as % of daily volume

12%25%38%51%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$697.3K (14 inflow days, 6 outflow days).

Net flow by order size, last 20 sessions

−$140.9KSuper+$838.2KBig+$81.6KMid+$407.6KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.8% of shares outstanding.

Largest holders

  • FMR13.01%
  • SR One Capital Management, LP7.92%
  • TPG Capital, L.P.7.70%
  • Jeito Capital S.A.7.70%
  • Lightspeed Management Company, LLC7.53%
  • Dimension Management, L.P.6.95%
  • Institutional Venture Partners7.53%
  • OrbiMed Advisors LLC6.26%

By investor type

  • VC/PE Fund53.37%
  • Mutual Fund20.75%
  • Hedge Fund13.32%
  • Public Company4.52%
  • Individual/Insider2.39%
  • Endowment Fund0.10%
  • Private Company0.03%
  • Government Pension Fund0.02%

Reported short interest has risen from 4.68% to 6.97% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +1,059,975 13.0%
BlackRock Mutual Fund 2026/Q3 +903,397 2.4%
FMR Mutual Fund 2026/Q3 +5,179,262 10.8%
SR One Capital Management, LP VC/PE Fund 2026/Q3 +3,794,883 7.9%
TPG Capital, L.P. VC/PE Fund 2026/Q3 +3,690,146 7.7%
Lightspeed Management Company, LLC VC/PE Fund 2026/Q3 +3,608,443 7.5%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +3,001,198 6.3%
Sanofi Public Company 2026/Q3 +1,991,918 4.2%
Deerfield Management Company, L.P. Hedge Fund 2026/Q3 +1,046,139 2.2%
Sands Capital Alternatives, LLC VC/PE Fund 2026/Q3 +875,000 1.8%
Hillhouse Capital Management, Ltd. VC/PE Fund 2026/Q3 +831,656 1.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +821,345 1.7%
General Catalyst Group Management, LLC VC/PE Fund 2026/Q3 +810,272 1.7%
Affinity Asset Advisors, LLC Hedge Fund 2026/Q3 +766,346 1.6%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +725,000 1.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 May 2026 TPG Capital, L.P. Other Acquisition +423,111 – –
10 May 2026 TPG Capital, L.P. Other Disposition -2,351 $18.00 –
10 May 2026 TPG Capital, L.P. Private Acquisition +1,388,889 $18.00 –
10 May 2026 TPG Capital, L.P. Other Derivative Disposition -423,111 – –
10 May 2026 TPG Capital, L.P. Derivative Exercise and Retained +1,880,497 – –
10 May 2026 Jeffrey Leiden Independent Chairperson Derivative Exercise and Sale -17 $18.00 301,842
10 May 2026 Jeffrey Leiden Independent Chairperson Derivative Exercise and Retained +31,644 – 301,842
10 May 2026 Shelley Chu Independent Director Private Acquisition +11,111 $18.00 11,111
10 May 2026 Gary Glick Chief Executive Officer Derivative Exercise and Retained +27,386 – 415,973
10 May 2026 Anthony Opipari Chief Medical Officer Derivative Exercise and Sale -4 $18.00 7,502
10 May 2026 Anthony Opipari Chief Medical Officer Derivative Exercise and Retained +7,502 – 7,502
10 May 2026 SR One Capital Management, LP Private Acquisition +555,555 $18.00 3,794,883
10 May 2026 SR One Capital Management, LP Derivative Exercise and Sale -1,780 $18.00 3,794,883
10 May 2026 SR One Capital Management, LP Derivative Exercise and Retained +3,239,328 – 3,794,883
10 May 2026 Dimension Management, L.P. Private Acquisition +1,111,111 $18.00 3,333,516
10 May 2026 Dimension Management, L.P. Derivative Exercise and Retained +1,709,543 – 3,333,516
7 May 2026 Jeffrey Leiden Independent Chairperson Private Acquisition +5,000 $20.00 301,842
7 May 2026 Jason Haas Chief Financial Officer Open Market Acquisition +1,000 $20.00 62,908
6 May 2026 TPG Capital, L.P. Initial Statement of Beneficial +0 – 1,880,497
6 May 2026 Jeffrey Leiden Independent Chairperson Other Derivative Acquisition +626,220 $18.00 626,220

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 3,347,791 7.0% 15.4
15 Oct 2026 3,281,824 6.8% 12.4
30 Sep 2026 3,105,465 6.5% 5.6
15 Sep 2026 2,208,686 4.6% 10.8
31 Aug 2026 2,208,908 4.6% 12.8
14 Aug 2026 2,249,359 4.7% 18.7

Discussion

No comments yet — be the first to weigh in on ODTX.

Sign in to join the discussion.

Scroll to Top